You are here
Extracorporeal Membrane Oxygenation Market to Hit $370 Million by 2025: Global Market Insights, Inc.
SELBYVILLE, Delaware, Oct. 9, 2019 /PRNewswire/ -- Global Extracorporeal Membrane Oxygenation Market is poised to cross USD 370 million by 2025; according to a new research report by Global Market Insights, Inc. Increasing government funding for development and advancement in extracorporeal membrane oxygenation including the ECMO PK Project will augment extracorporeal membrane oxygenation industry growth over the foreseeable future. Recent technological advancement in extracorporeal membrane oxygenation (ECMO) increasing the clinical utility and success rate of the device for treating respiratory and pediatric cardiac failures will positively impact the market growth.
Rising incidence of cardiopulmonary disease, chronic obstructive pulmonary disorder (COPD) and respiratory failure across the globe will offer robust potential to the global extracorporeal membrane oxygenation market growth during the forecast timeframe. As per the World Health Organization, around 65 million people suffer from chronic obstructive pulmonary disorder (COPD) annually and nearly 3 million die due to the condition every year globally. In 2016, about 17.9 million people died due to cardiovascular disease (CVD), accounting for around 31% of the total deaths worldwide. Growing adoption of unhealthy habits including tobacco smoking will lead to rising incidence of respiratory disorders propelling the market growth over the projected timeframe.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2720
Venoarterial ECMO accounted for USD 131.3 million in the year 2018. Venoarterial shows greater survival rate in comparison to Veno-venous ECMO. It helps in facilitating gaseous exchange in patients suffering from respiratory and cardiac failure. Recent technological advancement in venoarterial ECMO machine has increased the chances of survival of the patients suffering from severe cardiovascular condition including cardiac arrest. The largest share of this segment can be attributed to rising respiratory failure cases, lung transplants and growing incidence of COPD. Veno-venous ECMO market is expected to show considerable growth during the forecast period due to factors such as lower risk of barotrauma and oxygen toxicity resulting in market growth in the near future.
Extracorporeal Membrane Oxygenation Market Statistics, By Modality
1.1. Key segment trends
1.2. Venoarterial (VA)
1.2.1. Market size, by region, 2014 - 2025
1.3. Veno-venous (VV)
1.3.1. Market size, by region, 2014 - 2025
1.4. Arteriovenous (AV)
1.4.1. Market size, by region, 2014 – 2025
Respiratory disease segment accounted for over 60% market share in 2018 and is anticipated to witness considerable growth during the forecast period. Respiratory diseases are the most commonly occurring diseases with high mortality rate. Thus, increasing cases of lung cancer, respiratory failure and lung implants has elevated the adoption of ECMO technology in the hospital thereby driving the extracorporeal membrane oxygenation market. Extracorporeal cardiopulmonary resuscitation segment will witness substantial market growth in the upcoming years, due to rise in use of ECMO in treating cardiac disorders coupled with technological advancements in the device.
Browse key industry insights spread across 141 pages with 90 market data tables & 8 figures & charts from the report, "Global Extracorporeal Membrane Oxygenation Market Size By Modality (Venoarterial, Veno- Venous, Arteriovenous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult), Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, China, Japan, India, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Kuwait, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025" in detail along with the table of contents:
Infant segment accounted for over USD 125 million in 2018. According to the CDC data, nearly 1% of newborn babies in the U.S. suffer from congenital heart defects (CHD). ECMO is the proven treatment procedure for various cardiac and respiratory disorders in the infants, that upsurge the survival rate up to 80-90% in the infants. Thus, adoption of extracorporeal membrane oxygenation technology in infants will grow significantly over the years.
U.S. market will witness considerable growth during the forecast timeframe to reach USD 113 million by 2025. Rising incidence of respiratory and cardiac disorders will act as major driving factors for the growth of U.S. market. Advanced healthcare facilities, increasing government funding and high technological adoption will propel the business growth over the projected timeframe.
China extracorporeal membrane oxygenation market will expand at 3.8% CAGR during the forecast period. According to recent study, China has substantial number of respiratory and cardiac disorder patients. Rising awareness about extracorporeal membrane oxygenation coupled with rising incidence of chronic respiratory diseases such as allergic rhinitis (AR), asthma, chronic obstructive pulmonary disease (COPD) and other disorders will provide lucrative growth opportunities for China market in the future.
Getinge, LivaNova, Medtronic, Terumo, Abbott, and Alung Technologies are some of the major players functioning in the global extracorporeal membrane oxygenation market. Launch of advanced technology equipment's and strategic alliances are the key strategies implemented by these firms to enhance their market footprint and achieve substantial market share. For instance, in October 2018, MC3 announced the launch of the Crescent for extracorporeal membrane oxygenation (ECMO) in the U.S. The new product launch strengthened the company's position in the market as well as expanded its product portfolio.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2720
Browse Related Reports:
Patient Monitoring Devices Market Forecasts 2019-2025: North American market revenue anticipated to witness more than 4% growth in forthcoming future. Sedentary lifestyle, consumption of junk food and lack of exercise has boosted incidences of chronic conditions such as cardiovascular diseases and endocrine disorders due to rise in cholesterol levels. Key players operational in the global market are Skanray Technologies, Philips, Siemens Healthineers, Medion Healthcare, GE Healthcare, Nihon Kohden, OSI Systems, Epsimed, Sensata Technologies, Fukuda, Mindray, Medtronics and Hill -Rom Holdings.
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688